Here's the interesting question: If J&J is not at 95% efficacy, but closer to, say, 70%, will people want that vaccine or will they be holding out for Pfizer/Moderna? I could see a situation where J&J isn't effective enough and people want to bide their time for Moderna/Pfizer.
you get the JNJ. And get the Pfizer in the fall